An underground economy for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.
Investigational Treatment Gaining Traction Online
Retatrutide, which remains in research studies, is being advertised by online personalities for its alleged weight-reducing effects. Followers are urged to message these accounts directly for supplier links, while also obtaining promotional offers.
Active Commerce on Social Networks
Separately, a flourishing market exists on Telegram, where communities with thousands of members share “before and after” images, injection guides and claims of rapid UK delivery. Vendors promote the substance there before directing buyers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.
Medical Professionals Voice Worries
Nevertheless, doctors and pharmacists have warned that the sale of what is still an unlicensed medication in the UK is a cause for concern and could result in individuals administering products of uncertain source.
Several professionals stated the popularity for retatrutide could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or prison.
Service Reaction and Content Elimination
According to the social media company, the service has removed violative material and prohibited related keywords and query recommendations. The company stated it was dedicated to maintaining the platform safe and investing in enhancing enforcement strategies.
Digital Marketplace Activities
Investigations also discovered communities with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of users, filled with images of weight loss, glowing testimonials and detailed guides for mixing or administering at home.
After moments of entering one group, a seller posted WhatsApp details, where most transactions occur. The vendor sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or previous experience.
Product Details and Costs
Inside these groups, messages display black plastic parcels with postal service labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When asked how much time a pen should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for Telegram said it regularly moderated harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting materials they can’t verify. Even if the science behind retatrutide is sound, these online versions may not include what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the increase in interest to recent cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake injections are extremely risky. You cannot know what’s inside or whether the conditions they were made in was sterile,” she explained.
Her team has already encountered individuals harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company experimental substance not yet approved … may subject patients to possibly serious health risks”.
